NEW YORK (GenomeWeb) — Scientists from Virginia Tech's Carilion Research Institute have created a molecular toolkit in order to visualize and structurally analyze the BRCA1 protein and its associated parts in a near-native environment. 

"[Using this technology] we were able to make models about how this suspicious region doesn’t work properly [in mutated BRCA1 genes]," said Deborah Kelly, lead author and assistant professor of biological sciences in Virginia Tech’s College of Science, in an interview. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.